World practice of providing scientific advice on the development and authorisation of innovative medicines
Current challenges to healthcare, i.e. the emergence of new diseases, lack of therapies for known diseases and life-threatening conditions, identification of patients who do not respond to standard treatment, on the one hand, and the evolution of scientific understanding of disease processes, medici...
Saved in:
Main Authors: | E. V. Melnikova, O. V. Merkulova, V. A. Merkulov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2021-10-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/329 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multistakeholder scientific advice for medicinal products used in combination with a medical device or a companion diagnostic in the EU—summary of a Focus group discussion
by: Stiina Aarum, et al.
Published: (2025-07-01) -
Current Trends in the Use of Cell Therapy in Regenerative Medicine
by: A. A. Chaplenko, et al.
Published: (2020-06-01) -
Clinical trials for cellular therapy products: conclusions reached by foreign regulatory bodies
by: E. V. Melnikova, et al.
Published: (2020-07-01) -
Biomedical Cell Products or High-Tech Drugs?
by: V. A. Merkulov, et al.
Published: (2019-06-01) -
Utilisation of Business Advice in Small Innovative Firms: the Role of Trust and Tacit Knowledge
by: Katarzyna Łobacz, et al.
Published: (2016-06-01)